Unlike Pfizer, Moderna can meet 2023 Covid forecast, analysts say
NEW YORK, Nov 1 — Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its Covid vaccine to reach...
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, Nov 1 — Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its Covid vaccine to reach...
By Deena Beasley (Reuters) -Amgen on Tuesday said third-quarter sales rose 5%, but a full-year sales forecast raise only reflected additional revenue from ...
With the pandemic boom for makers of vaccines and testing kits unravelling, investors are turning their focus to sectors such as weight-loss drugs
Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid shots.
The waning of the COVID-19 pandemic is reshaping the healthcare industry once again. Vaccine makers and pharmacy chains are seeing a decline in the number of people getting COVID shots, while makers of at-home rapid tests are going out of business. Companies that produced personal protective equipment have also shut down. The shift in demand is evident as Pfizer cuts $9 billion from its annual sales forecast due to declining demand for its COVID shots. While some healthcare businesses are benefiting from the return of routine checkups and procedures, others are feeling the pressure to adjust t...